M. G. González Rodriguez

290P Potential enrichment strategies for next-generation sequencing (NGS) in primary brain cancers (pBCs) in a clinical series according to ESMO scale for clinical actionability of molecular targets (ESCAT)

O. Mirallas, E. Martínez-Sáez, F. Ros Montañá, 2022, Annals of Oncology.

Validation of Bromodomain and Extraterminal proteins as therapeutic targets in neurofibromatosis type 2

Douglas C. Miller, J. Kissil, M. Kareta, 2022, Neuro-oncology advances.